{"id":57435,"date":"2023-05-18T19:03:20","date_gmt":"2023-05-18T17:03:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/"},"modified":"2023-05-18T19:03:20","modified_gmt":"2023-05-18T17:03:20","slug":"applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/","title":{"rendered":"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023"},"content":{"rendered":"
\n

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc.<\/a> (NasdaqCM: AUVI<\/a>) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, used by clients globally, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, May 23, 2023 at 9:00 am ET to review its financial results. First quarter 2023 financial results will be released after market close on Monday, May 22, 2023 and will be available through the Investor Relations section of the company’s website at https:\/\/irdirect.net\/AUVI<\/a>.<\/p>\n

\nConference Call\/Webcast Information<\/b><\/p>\n

\nApplied UV’s management team will host an investor conference call and live webcast on May 23, 2023, at 9:00 am ET. Investors can access the live webcast via a link on Applied UV’s web site or at https:\/\/www.webcaster4.com\/Webcast\/Page\/2626\/48458<\/a>. For those planning to participate on the call, please dial +1-888-506-0062 (for domestic calls), or +1-973-528-0011 (for international calls), passcode 837349. A replay of the conference call will be available online on the Applied UV web site, and a dial-in replay will be available for one week following the call at +1-877-481-4010 (for domestic calls) or +1-919-882-2331 (for international calls), replay passcode 48458.<\/p>\n

\nAbout Applied UV<\/b><\/p>\n

\nApplied UV, Inc. provides proprietary surface and air pathogen elimination and disinfection technology focused on Improving Indoor Air Quality (IAQ), specialty LED lighting and luxury mirrors and commercial furnishings all of which serves clients globally in both the commercial and retail segments.<\/p>\n

\nOur products address the needs in the healthcare, hospitality, food preservation, cannabis, education, and winery vertical markets. The Company has established strategic manufacturing partnerships and alliances with such Companies as, Canon Virginia Inc, Canon Financial Services Inc., Acuity Brands Lighting, Johnson Controls International, USHIO, Siemens, W.W. Grainger, and maintains a global network of 89 dealers and distributors in 52 countries, offering a complete suite of products through its two wholly owned subsidiaries – SteriLumen, Inc. (\u201cSteriLumen\u201d) and Munn Works, LLC (\u201cMunnWorks\u201d). SteriLumen owns brands and markets a portfolio of clinically proven products utilizing advanced UVC Carbon, UVC LED\u2019s, Far UV (222nm), Photo-catalytic oxidation (PCO) pathogen elimination and disinfection technology, branded Airocide \u2122, Scientific Air\u2122, Airoclean\u2122 420, Lumicide\u2122, PUROHealth, and PURONet. SteriLumen\u2019s proprietary platform suite of patented, surface and air pathogen elimination and disinfection technologies offers complete pathogen disinfection platform. Our product suite includes mobile, fixed and HVAC systems and software solutions interconnecting its entire portfolio suite into the IoT allowing customers to implement, manage and monitor IAQ measures recommended by the EPA across any enterprise. SteriLumen\u2019s Lumicide\u2122 platform applies the power of ultraviolet light (UVC) to destroy pathogens automatically, addressing the challenge of healthcare-acquired infections (HAIs) in several patented designs for infection control in healthcare.<\/p>\n

\nLED Supply Co. is a full-service, wholesale distributor of LED lighting and controls used throughout facilities in North America.<\/p>\n

\nMunnWorks manufactures and sells custom luxury and backlit mirrors, and conference room and living spaces furnishings.<\/p>\n

\nOur global list of Fortune 100 end users including Kaiser Permanente, NY Health+Hospitals, MERCY Healthcare, Baptist Health South Florida, New York City Transit, Samsung, JB Hunt, Boston Red Sox\u2019s Fenway Park, JetBlue Park, France\u2019s Palace of Versailles, Whole Foods, Del Monte Foods, U.S. Department of Veterans Affairs, Marriott, Hilton, Four Seasons and Hyatt, and more. For information on Applied UV, Inc., and its subsidiaries, please visit https:\/\/www.applieduvinc.com<\/a>.<\/p>\n

\nForward-Looking Statements<\/b><\/p>\n

\nThe information contained herein may contain \u201cforward\u2010looking statements.\u201d Forward\u2010looking statements reflect the current view about future events. When used in this press release, the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cplan,\u201d or the negative of these terms and similar expressions, as they relate to us or our management, identify forward\u2010looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward\u2010looking statements are based on the Company\u2019s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward\u2013looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company\u2019s actual results may differ materially from those contemplated by the forward\u2010looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward\u2010looking statements. Factors or events that could cause the Company\u2019s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward\u2010looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.<\/p>\n

Contacts<\/b> <\/p>\n

\nBrett Maas, Managing Principal
\n
Hayden IR
\n
brett@haydenir.com<\/a>
(646) 536-7331<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, used by clients globally, announced that the Company will be hosting an investor conference … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57435","6":"format-standard","7":"category-industry"},"yoast_head":"\nApplied UV to Host First Quarter 2023 Conference Call on May 23, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, used by clients globally, announced that the Company will be hosting an investor conference ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-18T17:03:20+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023\",\"datePublished\":\"2023-05-18T17:03:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/\"},\"wordCount\":880,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/\",\"name\":\"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-05-18T17:03:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/","og_locale":"en_US","og_type":"article","og_title":"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023 - Pharma Trend","og_description":"MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, used by clients globally, announced that the Company will be hosting an investor conference ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-18T17:03:20+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023","datePublished":"2023-05-18T17:03:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/"},"wordCount":880,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/","url":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/","name":"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-05-18T17:03:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-first-quarter-2023-conference-call-on-may-23-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Applied UV to Host First Quarter 2023 Conference Call on May 23, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57435"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57435\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}